Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Cash from Investing Activities: 2020-2024

Historic Cash from Investing Activities for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $46.2 million.

  • Oncology Institute's Cash from Investing Activities fell 10580.66% to -$604000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year decrease of 10329.01%. This contributed to the annual value of $46.2 million for FY2024, which is 2622.77% down from last year.
  • According to the latest figures from FY2024, Oncology Institute's Cash from Investing Activities is $46.2 million, which was down 2622.77% from $62.6 million recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Cash from Investing Activities peaked at $62.6 million during FY2023, and registered a low of -$131.6 million during FY2022.
  • Over the past 5 years, Oncology Institute's median Cash from Investing Activities value was -$8.8 million (recorded in 2020), while the average stood at -$8.8 million.
  • As far as peak fluctuations go, Oncology Institute's Cash from Investing Activities crashed by 98288.63% in 2022, and later soared by 14759.37% in 2023.
  • Annual analysis of 5 years shows Oncology Institute's Cash from Investing Activities stood at -$8.8 million in 2020, then crashed by 37.43% to -$12.2 million in 2021, then crashed by 982.89% to -$131.6 million in 2022, then soared by 147.59% to $62.6 million in 2023, then dropped by 26.23% to $46.2 million in 2024.
  • Its last three reported values are $46.2 million in FY2024, $62.6 million for FY2023, and -$131.6 million during FY2022.